Ads
related to: kmph stockThese Top Brokerages Offer Tools For New Investors And Those With Years Of Experience. New And Experienced Investors Should Consider These Top-Recommended Brokerages.
Invest in the AI supply chain with these 5 overlooked stocks. Free report available now. New free special report reveals 5 stocks driving the massive growth in the AI explosion.
Join the Ranks of Successful Traders with Our Senior Analysts' Free Trade Alerts! Our algorithm scans 15,000 stocks per day so you don't have to. Get the free alerts now.
Trade Stocks, Bonds, Options, ETFs, And Mutual Funds, All In One Easy-To-Manage Account. Buy, Sell, and Learn About The Stock Market With Access To Our Wide Suite Of Tools
Search results
Get the latest stock price, volume, high, low and 52-week range of KemPharm, Inc. (KMPH) on Nasdaq. See the intraday chart, the last-five real-time trades and sales data for KMPH.
Kempharm Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Nov 9, 2022 · KemPharm, a biopharmaceutical company developing novel prodrugs, announced its financial and operational results for the third quarter of 2022. The company also provided an update on its pipeline candidates, including Zevra Therapeutics, a subsidiary focused on rare diseases.
People also ask
Why did Kempharm stock rise 71% on Monday?
How much does Kempharm (kmph) stock cost?
What did Kempharm (kmph) report in Q2 2022?
Yahoo Finance
May 17, 2022 · KemPharm, a biopharmaceutical company, announced a $12.8 million deal to buy Orphazyme, a Denmark-based firm with a pipeline candidate for Niemann-Pick disease type C. The acquisition is expected to boost KemPharm's rare CNS disease portfolio, but the stock has plunged 49.6% this year.
KMPH - KemPharm, Inc. Stock Price and Quote. TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. ×. KMPH [NASD] KemPharm, Inc. Healthcare | Biotechnology | USA. statements.
Kempharm is a biopharmaceutical company developing novel treatments for central nervous system disorders. The web page provides the latest stock price, company overview and news of Kempharm, as well as other articles on various topics.
